[go: up one dir, main page]

MX2019001214A - Metodos para el diagnostico de neoplasia de origen ginecologico. - Google Patents

Metodos para el diagnostico de neoplasia de origen ginecologico.

Info

Publication number
MX2019001214A
MX2019001214A MX2019001214A MX2019001214A MX2019001214A MX 2019001214 A MX2019001214 A MX 2019001214A MX 2019001214 A MX2019001214 A MX 2019001214A MX 2019001214 A MX2019001214 A MX 2019001214A MX 2019001214 A MX2019001214 A MX 2019001214A
Authority
MX
Mexico
Prior art keywords
neoplasia
diagnosis
methods
gynecological
origin
Prior art date
Application number
MX2019001214A
Other languages
English (en)
Inventor
Cheng Lai Hung-
Original Assignee
Univ Taipei Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Taipei Medical filed Critical Univ Taipei Medical
Publication of MX2019001214A publication Critical patent/MX2019001214A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/57535—
    • G01N33/5755—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/12—Post-translational modifications [PTMs] in chemical analysis of biological material alkylation, e.g. methylation, (iso-)prenylation, farnesylation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En la presente se describen diversos métodos para evaluar la presencia de neoplasia de origen ginecológico o la malignidad de la neoplasia de origen ginecológico, en función de la hipermetilación de uno o más genes marcadores.
MX2019001214A 2016-07-29 2017-07-28 Metodos para el diagnostico de neoplasia de origen ginecologico. MX2019001214A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662368182P 2016-07-29 2016-07-29
PCT/CN2017/094917 WO2018019294A1 (en) 2016-07-29 2017-07-28 Methods for gynecologic neoplasm diagnosis

Publications (1)

Publication Number Publication Date
MX2019001214A true MX2019001214A (es) 2019-09-19

Family

ID=61015645

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019001214A MX2019001214A (es) 2016-07-29 2017-07-28 Metodos para el diagnostico de neoplasia de origen ginecologico.

Country Status (16)

Country Link
US (1) US20190153544A1 (es)
EP (1) EP3490612B1 (es)
JP (3) JP6767512B2 (es)
KR (1) KR102258887B1 (es)
CN (1) CN109069670B (es)
AU (1) AU2017304949B2 (es)
BR (1) BR112019001712A2 (es)
CA (1) CA3032038A1 (es)
IL (1) IL264542B2 (es)
MX (1) MX2019001214A (es)
NZ (1) NZ750327A (es)
RU (1) RU2723531C1 (es)
SG (2) SG10202101024UA (es)
TW (1) TWI648403B (es)
WO (1) WO2018019294A1 (es)
ZA (1) ZA201900570B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113337614A (zh) * 2021-08-05 2021-09-03 北京起源聚禾生物科技有限公司 子宫内膜癌早期筛查诊断用标志物、引物探针及试剂盒
EP4130297A1 (en) * 2021-08-05 2023-02-08 Beijing OriginPoly Bio-Tec Co., Ltd. Markers, primers, probes and kit for early screening and diagnosis of endometrial cancer
EP4265738A4 (en) 2022-03-03 2025-05-07 Beijing OriginPoly Bio-Tec Co., Ltd. Combination of DNA methylation markers and their use, primers, probes and kit for the early detection of ovarian cancer
CN114921549B (zh) * 2022-06-06 2025-09-09 重庆摩斯码可生物科技有限公司 乳腺癌生物标志物znf662基因及其检测方法与应用
CN115725591A (zh) * 2022-09-22 2023-03-03 上海奕谱生物科技有限公司 新型的肿瘤检测标志物TAGMe及其应用
TWI872797B (zh) * 2023-11-10 2025-02-11 酷氏基因生物科技股份有限公司 子宮內膜癌的診斷方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005115388A1 (en) * 2004-05-12 2005-12-08 Biorunx Co., Ltd. A therapeutic agent containing nicotinic acid or its derivatives as an effective ingredient for prevention and treatment of cancer
US7754428B2 (en) * 2006-05-03 2010-07-13 The Chinese University Of Hong Kong Fetal methylation markers
CN101230399B (zh) * 2008-01-07 2010-06-02 中国科学院化学研究所 一种检测dna甲基化的方法
CN105586408B (zh) * 2008-04-29 2021-03-23 赖鸿政 一种癌症筛检的方法
US9458495B2 (en) * 2008-07-01 2016-10-04 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for assessment of clinical infertility
CN101864480B (zh) * 2009-04-17 2013-12-18 国防医学院 一种癌症筛检的方法
US20110195848A1 (en) * 2010-01-08 2011-08-11 Roopra Avtar S Gene expression and breast cancer
WO2012120374A2 (en) * 2011-03-10 2012-09-13 Oslo Universitetssykehus Hf Methods and biomarkers for detection of gastrointestinal cancers
NZ622148A (en) * 2011-08-30 2016-06-24 Nat Defense Medical Ct Gene biomarkers for prediction of susceptibility of ovarian neoplasms and/or prognosis or malignancy of ovarian cancers
WO2013174432A1 (en) * 2012-05-24 2013-11-28 Fundació Institut D'investigació Biomèdica De Bellvitge (Idibell) Method for the identification of the origin of a cancer of unknown primary origin by methylation analysis
CN109457030B (zh) * 2012-10-29 2022-02-18 约翰·霍普金斯大学 卵巢和子宫内膜癌的帕帕尼科拉乌测试
CN104513851B (zh) * 2013-10-08 2017-01-11 陈永恩 侦测膀胱癌的新颖表基因生物标记及其方法
CN120700143A (zh) * 2014-03-31 2025-09-26 梅奥医学教育和研究基金会 检测结直肠赘生物
WO2016049024A2 (en) * 2014-09-24 2016-03-31 The Broad Institute Inc. Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling competition of multiple cancer mutations in vivo
WO2016115354A1 (en) * 2015-01-14 2016-07-21 Taipei Medical University Methods for cancer diagnosis and prognosis

Also Published As

Publication number Publication date
NZ750327A (en) 2022-07-29
JP2021019587A (ja) 2021-02-18
EP3490612B1 (en) 2024-08-21
EP3490612A1 (en) 2019-06-05
SG11201900589PA (en) 2019-02-27
SG10202101024UA (en) 2021-03-30
JP2019524058A (ja) 2019-09-05
JP2022036935A (ja) 2022-03-08
JP7182317B2 (ja) 2022-12-02
TWI648403B (zh) 2019-01-21
TW201805433A (zh) 2018-02-16
IL264542A (en) 2019-05-30
JP6767512B2 (ja) 2020-10-14
CN109069670B (zh) 2022-05-10
EP3490612C0 (en) 2024-08-21
IL264542B2 (en) 2024-02-01
RU2723531C1 (ru) 2020-06-16
CN109069670A (zh) 2018-12-21
BR112019001712A2 (pt) 2019-05-07
AU2017304949B2 (en) 2024-06-20
KR102258887B1 (ko) 2021-06-01
US20190153544A1 (en) 2019-05-23
EP3490612A4 (en) 2020-04-01
ZA201900570B (en) 2019-10-30
KR20190025941A (ko) 2019-03-12
JP6971502B2 (ja) 2021-11-24
AU2017304949A1 (en) 2019-02-21
WO2018019294A1 (en) 2018-02-01
IL264542B1 (en) 2023-10-01
CA3032038A1 (en) 2018-02-01

Similar Documents

Publication Publication Date Title
MX2019001214A (es) Metodos para el diagnostico de neoplasia de origen ginecologico.
CO2019008783A2 (es) Compuestos dinucleotidos ciclicos para el tratamiento del cancer
CO2017004736A2 (es) Péptidos macrociclicos útiles como inmunomoduladores
NI201700060A (es) Agonistas parciales del receptor de insulina
CL2019002612A1 (es) Compuestos macrocíclicos como inhibidores de la quinasa ros1.
CL2016002394A1 (es) Derivados de quinolina como inhibidores de smo
ECSP17073743A (es) Moduladores de k-ras
UY35908A (es) Moduladores de tetrahidropiridopirazinas de gpr6
CL2015003491A1 (es) Compuestos químicos.
UY34657A (es) ?derivados macrocíclicos para el tratamiento de enfermedades?.
MX2018006148A (es) Inhibidores de cxcr2.
GT201500004S (es) Diseño de carro de juguete (diseño fraccionario de la solicitud no. s-201500004)
GT201500001S (es) Diseño de carro de juguete (diseño fraccionario de la solicitud no. s-201500001)
MX2017008179A (es) Proceso para la preparacion de un compuesto de diariltiohidantoina.
CO2017002374A2 (es) Pigmentos rojos de óxido de hierro con valores cromáticos mejorados
MX2019012734A (es) Procesos para la preparacion de un compuesto de diariltiohidantoina.
TWD172815S (zh) 戒指
ECSP16074207A (es) Pirazinas moduladoras de gpr6
CL2017000151A1 (es) Derivados de piridona
MX2016016507A (es) Composiciones y metodos para tratar canceres.
EP4428251A3 (en) Methods of detecting prostate cancer
CO2017010143A2 (es) Procesos para preparar fluorocetólidos
BR112016028948A2 (pt) ?composição bifásica?
MX2017008373A (es) Compuestos, composiciones y metodos.
MX2018003802A (es) Formulacion de hipericina para el diagnostico fotodinamico.